As filed with the Securities and Exchange Commission on August 2, 1996
                                                  Registration No. 333-

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                                     
                                    FORM S-8
            REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
                                                     
                            SEROLOGICALS CORPORATION
              (Exact name of issuer as specified in its charter)
                Delaware                              58-2142225
     (State or other jurisdiction of       (I.R.S. Employer Identification
      incorporation or organization)                    Number)

                         780 Park North Blvd., Suite 110
                            Clarkston, Georgia 30021
               (Address of principal executive offices) (Zip Code)
                            ________________________
                            SEROLOGICALS CORPORATION
                            1996 UK SHARESAVE SCHEME
                            (Full title of the Plan)

                            Harold J. Tenoso, Ph.D.
                              President and Chief
                               Executive Officer 
                            Serologicals Corporation
                         780 Park North Blvd., Suite 110
                            Clarkston, Georgia 30021
                                 (404) 296-5595
                      (Name, address and telephone number,
                   including area code, of agent for service)
                                   Copies to:
                            David S. Rosenthal, Esq.
                   Shereff, Friedman, Hoffman & Goodman, LLP
                                919 Third Avenue
                            New York, New York  10022
                                 (212) 758-9500
                        CALCULATION OF REGISTRATION FEE
 Title of                       Proposed        Proposed
Securities                      Maximum          Maximum         Amount of
  to be       Amount to be   Offering Price     Aggregate     Registration
Registered     Registered(1)    Per Share     Offering Price        Fee
- --------------------------------------------------------------------------
Common Stock,
par value        20,000
$0.01 per share  shares          $24.25(2)       $485,000(2)       $167.24
(1)  Pursuant to Rule 416, this Registration Statement also covers such 
additional securities as may become issuable to prevent dilution resulting 
from stock splits, stock dividends or similar transactions.
(2)  Estimated solely for the purpose of calculating the registration fee 
pursuant to Rule 457(h), based of the average of the high and low sale 
prices of the Registrant's Common Stock as quoted on The Nasdaq National 
Market on July 25, 1996. 

<PAGE>

PART II

INFORMATION REQUIRED IN
THE REGISTRATION STATEMENT

Item 3.     Incorporation of Documents by Reference

     The following documents, which have been filed by Serologicals 
Corporation, a Delaware corporation (the "Registrant"), with the 
Securities and Exchange Commission (the "Commission"), are incorporated 
herein by reference:

     (a)     The Registrant's Annual Report on Form 10-K for the year     
             ended December 31, 1995;

     (b)     The Registrant's Quarterly Report on Form 10-Q for the period 
             ended March 31, 1996;

     (c)     The Registrant's Current Report on Form 8-K dated March 6, 
             1996 as amended by its Current Report on Form 8-K/A dated 
             April 30, 1996; and

     (d)     The section of the Registrant's Form 8-A, filed on May 17, 
             1995, pursuant to Section  12(g) of the Securities Exchange 
             Act of 1934, as amended (the "Exchange Act"), entitled 
             "Description of Registrant's Securities to be Registered."

	In addition, all documents subsequently filed by the Registrant 
pursuant to Section 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior 
to the filing of a post-effective amendment which indicates that all 
securities offered have been sold or which registers all securities then 
remaining unsold, shall be deemed to be incorporated by reference in this 
registration statement and to be a part hereof from the time of filing of 
such documents.

Item 4.     Description of Securities.

              Not applicable.

Item 5.     Interest of Named Experts and Counsel.

              Not applicable.

<PAGE>

Item 6.     Indemnification of Directors and Officers.

            The indemnification of officers and directors of the 
Registrant is governed by Section 145 of the General Corporation Law of 
the State of Delaware (the "DGCL") and the Amended and Restated 
Certificate of Incorporation of the Registrant.  Among other things, the 
DGCL permits indemnification of a director, officer, employee or agent in 
civil, criminal, administrative or investigative actions, suits or 
proceedings (other than an action by or in the right of the corporation) 
to which such person is a party or is threatened to be made a party by 
reason of the fact of such relationship with the corporation or the fact 
that such person is or was serving in a similar capacity with another 
entity at the request of the corporation against expenses (including 
attorneys' fees), judgments, fines and amounts paid in settlement actually 
and reasonably incurred by him or her if such person acted in good faith 
and in a manner he or she reasonably believed to be in or not opposed to 
the best interests of the corporation, and, with respect to any criminal 
action or proceeding, if he or she had no reasonable cause to believe his 
or her conduct was unlawful.  No indemnification may be made in any such 
suit to any person adjudged to be liable to the corporation unless and 
only to the extent that the Delaware Court of Chancery or the court in 
which the action was brought determines that, despite the adjudication of 
liability, such person is under all circumstances, fairly and reasonably 
entitled to indemnity for such expenses which such court shall deem 
proper.  Under the DGCL, to the extent that a director, officer, employee 
or agent is successful, on the merits or otherwise, in the defense of any 
action, suit or proceeding or any claim, issue or matter therein (whether 
or not the suit is brought by or in the right of the corporation), he or 
she shall be indemnified against expenses (including attorneys' fees) 
actually and reasonably incurred by him or her.  In all cases in which 
indemnification is permitted (unless ordered by a court), it may be made 
by the corporation only as authorized in the specific case upon a 
determination that the applicable standard of conduct has been met by the 
party to be indemnified.  The determination must be made by a majority 
vote of a quorum consisting of the directors who were not parties to the 
action or, if such a quorum is not obtainable, or even if obtainable, if a 
quorum of disinterested directors so directs, by independent legal counsel 
in a written opinion, or by the shareholders.  The statute authorizes the 
corporation to pay expenses incurred by an officer or director in advance 
of a final disposition of a proceeding upon receipt of an undertaking by 
or on behalf of the person to whom the advance will be made, to repay the 
advances if it shall ultimately be determined that he was not entitled to 
indemnification.  The DGCL provides that indemnification and advances of 
expenses permitted thereunder are not to be exclusive of any rights to 
which those seeking indemnification or advancement of expenses may be 
entitled under any By-law, agreement, vote of stockholders or 
disinterested directors, or otherwise.  The DGCL also authorizes the 
corporation to purchase and maintain liability insurance on behalf of its 
directors, officers, employees and agents regardless of whether the 
corporation would have the statutory power to indemnify such persons 
against the liabilities insured.

<PAGE>
            The Amended and Restated Certificate of Incorporation of the 
Registrant (the "Certificate") provides that no director of the Registrant 
shall be personally liable to the Registrant or its stockholders for 
monetary damages for breach of fiduciary duty as a director except for 
liability (i) for any breach of the director's duty of loyalty to the 
Registrant or its stockholders, (ii) for acts or omissions not in good 
faith or which involve intentional misconduct or a knowing violation of 
law, (iii) for paying a dividend or approving a stock repurchase in 
violation of Section 174 of the DGCL or (iv) for any transaction from 
which the director derived an improper personal benefit.

            In addition, the Certificate provides that directors, officers 
and others shall be indemnified to the fullest extent authorized by the 
DGCL, as in effect (or, to the extent indemnification is broadened, as it 
may be amended), against any and all expense, liability and loss 
(including settlement) reasonably incurred or suffered by such person in 
connection with such service.  The Certificate further provides that, to 
the extent permitted by law, expenses so incurred by any such person in 
defending any such proceeding shall, at his request, be paid by the 
Registrant in advance of the final disposition of such action or 
proceeding.

            The Certificate provides that the right to indemnification and 
the payment of expenses incurred in defending a proceeding in advance of 
its final disposition shall not be exclusive of any other right which any 
person may have or acquire under any law, provision of By-laws or 
otherwise.

            Pursuant to indemnification agreements with certain of its 
executive officers and directors, the Registrant has agreed to indemnify 
such persons (including their respective heirs, executors and 
administrators) to the fullest extent permitted by the DGCL against all 
expenses and liabilities reasonably incurred in connection with or arising 
out of any action, suit or proceeding in which such executive officer or 
director may be involved by reason of having been a director or officer of 
the Registrant or any subsidiary thereof.

            The Registrant maintains directors and officers liability and 
company reimbursement insurance which, among other things (i) provides for 
payment on behalf of its officers and directors against loss as defined in 
the policy stemming from acts committed by directors and officers in their 
capacity as such and (ii) provides for payment on behalf of the Registrant 
against such loss but only when the Registrant shall be required or 
permitted to indemnify directors or officers for such loss pursuant to 
statutory or common law or pursuant to duly effective certificate of 
incorporation or by-law provisions. 

<PAGE>
Item 7.     Exemption from Registration Claimed.

              Not applicable.

Item 8.     Exhibits

     The following exhibits are filed as part of this registration 
statement:

     5.1   Opinion of Shereff, Friedman, Hoffman & Goodman, LLP.

    23.1   Consent of Arthur Andersen LLP.

    23.2   Consent of Shereff, Friedman, Hoffman & Goodman, LLP (included 
           in Exhibit 5.1).

    24     Power of Attorney (included in signature page to this 
           registration statement).



Item 9.     Undertakings.

     (a)  The undersigned Registrant hereby undertakes:

          (1)  To file, during any period in which offers or sales are 
               being made, a post-effective amendment to this 
               registration statement:

                (i) To include any prospectus required by Section 
                    10(a)(3) of the Securities Act of 1933;

               (ii) To reflect in the prospectus any facts or events 
                    arising after the effective date of the 
                    registration statement (or the most recent post-
                    effective amendment thereof) which, individually
                    or in the aggregate, represent a fundamental 
                    change in the information set forth in the 
                    registration statement;

              (iii) To include any material information with respect 
                    to the plan of distribution not previously 
                    disclosed in the registration statement or any 
                    material change to such information in the 
                    registration statement;
<PAGE>
          PROVIDED, HOWEVER, that paragraphs (a)(1)(i) and (ii) do not 
apply if the registration statement is on Form S-3 or S-8 and the 
information required to be included in a post-effective amendment by those 
paragraphs is contained in periodic reports filed by the Registrant 
pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 
1934 that are incorporated by reference in the registration statement.

          (2)  That, for the purpose of determining any liability 
under the Securities Act of 1933, each such post-effective amendment shall 
be deemed to be a new registration statement relating to the securities 
offered therein, and the offering of such securities at that time shall be 
deemed to be the initial bona fide offering thereof.

          (3)  To remove from registration by means of a post-effective 
amendment any of the securities being registered which remain unsold at 
the termination of the offering.

(b)     The undersigned Registrant hereby undertakes that, for the 
purposes of determining any liability under the Securities Act of 1933, 
each filing of the Registrant's annual report pursuant to Section 13(a) or 
15(d) of the Securities Exchange Act of 1934 (and, where applicable, each 
filing of an employee benefit plan's annual report pursuant to Section 
15(d) of the Securities Exchange Act of 1934) that is incorporated by 
reference in the registration statement shall be deemed to be a new 
registration statement relating to the securities offered therein, and the 
offering of such securities at that time shall be deemed to be the initial 
bona fide offering thereof.

(c)     Insofar as indemnification for liabilities arising under the 
Securities Act of 1933 may be permitted to directors, officers and 
controlling persons of the Registrant pursuant to the foregoing 
provisions, or otherwise, the Registrant has been advised that in the 
opinion of the Securities and Exchange Commission such indemnification is 
against public policy as expressed in the Act and is, therefore, 
unenforceable.  In the event that a claim for indemnification against such 
liabilities (other than the payment by the Registrant of expenses incurred 
or paid by a director, officer or controlling person of the Registrant in 
the successful defense of any action, suit or proceeding) is asserted by 
such director, officer or controlling person in connection with the 
securities being registered, the Registrant will, unless in the opinion of 
its counsel the matter has been settled by controlling precedent, submit 
to a court of appropriate jurisdiction the question whether such 
indemnification by it is against public policy as expressed in the Act and 
will be governed by the final adjudication of such issue.

<PAGE>
SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, the 
Registrant certifies that it has reasonable grounds to believe that it 
meets all the requirements for filing on Form S-8 and has duly caused this 
Registration Statement to be signed on its behalf by the undersigned, 
thereunto duly authorized, in the City of Clarkson, State of Georgia, on 
this 30th day of July, 1996.

                               SEROLOGICALS CORPORATION


                               By:  /s/ Harold J. Tenoso          
                                    Harold J. Tenoso, Ph.D.	
                                    President, Chief Executive Officer
                                     and Director

     KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned whose 
signature appears below constitutes and appoints Harold J. Tenoso, Ph.D. 
and Russell H. Plumb, and each of them (with full power of each of them to 
act alone), his true and lawful attorneys-in-fact, with full power of 
substitution and resubstitution for him and on his behalf, and in his 
name, place and stead, in any all capacities to execute and sign any and 
all amendments or post-effective amendments to this registration 
statement, and to file the same, with all exhibits thereto, and other 
documents in connection therewith, with the Securities and Exchange 
Commission, hereby ratifying and confirming all that said attorneys-in-
fact or any of them or their or his substitute or substitutes, may 
lawfully do or cause to be done by virtue hereof and the Registrant hereby 
confers like authority on its behalf.

     Pursuant to the requirements of the Securities Act of 1933, the 
Registration Statement has been signed below by the following persons on 
behalf of the Registrant and in the capacities and on the dates indicated.

Signature                            Title                        Date

 /s/ Harold J. Tenoso           President, Chief Executive     Aug. 2 1996
- ---------------------           Officer and Director
Harold J. Tenoso, Ph.D.         (Prinicpal Executive Officer)

 /s/ Samuel A. Penninger, Jr.   Chairman of the Board of       Aug. 2 1996
- ----------------------------    Directors
Samuel A. Penninger, Jr.

 /s/ Marcia T. Bates            Director                       Aug. 2 1996
- --------------------
Marcia T. Bates

 /s/ James L. Currie            Director                       Aug. 2 1996
- --------------------
James L. Currie

 /s/ George M. Shaw             Director                       Aug. 2 1996
- -------------------
George M. Shaw, M.D., Ph.D.

/s/ Lawrence E. Tilton          Director                       Aug. 2 1996
- -----------------------
Lawrence E. Tilton

 /s/ Matthew C. Weisman         Director                       Aug. 2 1996
- -----------------------
Matthew C. Weisman

 /s/ Russell H. Plumb           Vice President, Finance and    Aug. 2 1996
- ---------------------           Administration and Chief 
Russell H. Plumb                Financial Officer (Principal
                                Financial and Accounting Officer)



<PAGE>

                         SEROLOGICALS CORPORATION


                                 FORM S-8
                         REGISTRATION STATEMENT


                              EXHIBIT INDEX

                                                              Sequentially
                                                                  Numbered
Exhibit                                                             Page


5.1     Opinion of Shereff, Friedman, Hoffman & Goodman, LLP.	

23.1    Consent of Arthur Andersen LLP.	

23.2    Consent of Shereff, Friedman, Hoffman & Goodman, LLP 
        (included in Exhibit 5.1).

24      Power of Attorney (included in signature page to this
        registration statement).
[{"type": "S-8", "sequence": "1", "secsgml_size_bytes": 19323}]
{"company-data": {"conformed-name": "SEROLOGICALS CORP", "cik": "0000767673", "assigned-sic": "2836", "irs-number": "582142225", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-09549", "film-number": "96603582"}, "business-address": {"street1": "780 PARK NORTH BLVD", "street2": "STE 110", "city": "CLARKSTON", "state": "GA", "zip": "30021", "phone": "4042965595"}, "mail-address": {"street1": "780 PARK NORTH BLVD", "street2": "STE 110", "city": "CLARKSTON", "state": "GA", "zip": "30021"}, "former-company": {"former-conformed-name": "SEROLOGICALS HOLDINGS INC", "date-changed": "19950418"}}
As filed with the Securities and Exchange Commission on August 2, 1996
                                                  Registration No. 333-

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                                     
                                    FORM S-8
            REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
                                                     
                            SEROLOGICALS CORPORATION
              (Exact name of issuer as specified in its charter)
                Delaware                              58-2142225
     (State or other jurisdiction of       (I.R.S. Employer Identification
      incorporation or organization)                    Number)

                         780 Park North Blvd., Suite 110
                            Clarkston, Georgia 30021
               (Address of principal executive offices) (Zip Code)
                            ________________________
                            SEROLOGICALS CORPORATION
                            1996 UK SHARESAVE SCHEME
                            (Full title of the Plan)

                            Harold J. Tenoso, Ph.D.
                              President and Chief
                               Executive Officer 
                            Serologicals Corporation
                         780 Park North Blvd., Suite 110
                            Clarkston, Georgia 30021
                                 (404) 296-5595
                      (Name, address and telephone number,
                   including area code, of agent for service)
                                   Copies to:
                            David S. Rosenthal, Esq.
                   Shereff, Friedman, Hoffman & Goodman, LLP
                                919 Third Avenue
                            New York, New York  10022
                                 (212) 758-9500
                        CALCULATION OF REGISTRATION FEE
 Title of                       Proposed        Proposed
Securities                      Maximum          Maximum         Amount of
  to be       Amount to be   Offering Price     Aggregate     Registration
Registered     Registered(1)    Per Share     Offering Price        Fee
- --------------------------------------------------------------------------
Common Stock,
par value        20,000
$0.01 per share  shares          $24.25(2)       $485,000(2)       $167.24
(1)  Pursuant to Rule 416, this Registration Statement also covers such 
additional securities as may become issuable to prevent dilution resulting 
from stock splits, stock dividends or similar transactions.
(2)  Estimated solely for the purpose of calculating the registration fee 
pursuant to Rule 457(h), based of the average of the high and low sale 
prices of the Registrant's Common Stock as quoted on The Nasdaq National 
Market on July 25, 1996.
PART II

INFORMATION REQUIRED IN
THE REGISTRATION STATEMENT

Item 3.     Incorporation of Documents by Reference

     The following documents, which have been filed by Serologicals 
Corporation, a Delaware corporation (the "Registrant"), with the 
Securities and Exchange Commission (the "Commission"), are incorporated 
herein by reference:

     (a)     The Registrant's Annual Report on Form 10-K for the year     
             ended December 31, 1995;

     (b)     The Registrant's Quarterly Report on Form 10-Q for the period 
             ended March 31, 1996;

     (c)     The Registrant's Current Report on Form 8-K dated March 6, 
             1996 as amended by its Current Report on Form 8-K/A dated 
             April 30, 1996; and

     (d)     The section of the Registrant's Form 8-A, filed on May 17, 
             1995, pursuant to Section  12(g) of the Securities Exchange 
             Act of 1934, as amended (the "Exchange Act"), entitled 
             "Description of Registrant's Securities to be Registered."

	In addition, all documents subsequently filed by the Registrant 
pursuant to Section 13(a), 13(c), 14 and 15(d) of the Exchange Act, prior 
to the filing of a post-effective amendment which indicates that all 
securities offered have been sold or which registers all securities then 
remaining unsold, shall be deemed to be incorporated by reference in this 
registration statement and to be a part hereof from the time of filing of 
such documents.

Item 4.     Description of Securities.

              Not applicable.

Item 5.     Interest of Named Experts and Counsel.

              Not applicable.
Item 6.     Indemnification of Directors and Officers.

            The indemnification of officers and directors of the 
Registrant is governed by Section 145 of the General Corporation Law of 
the State of Delaware (the "DGCL") and the Amended and Restated 
Certificate of Incorporation of the Registrant.  Among other things, the 
DGCL permits indemnification of a director, officer, employee or agent in 
civil, criminal, administrative or investigative actions, suits or 
proceedings (other than an action by or in the right of the corporation) 
to which such person is a party or is threatened to be made a party by 
reason of the fact of such relationship with the corporation or the fact 
that such person is or was serving in a similar capacity with another 
entity at the request of the corporation against expenses (including 
attorneys' fees), judgments, fines and amounts paid in settlement actually 
and reasonably incurred by him or her if such person acted in good faith 
and in a manner he or she reasonably believed to be in or not opposed to 
the best interests of the corporation, and, with respect to any criminal 
action or proceeding, if he or she had no reasonable cause to believe his 
or her conduct was unlawful.  No indemnification may be made in any such 
suit to any person adjudged to be liable to the corporation unless and 
only to the extent that the Delaware Court of Chancery or the court in 
which the action was brought determines that, despite the adjudication of 
liability, such person is under all circumstances, fairly and reasonably 
entitled to indemnity for such expenses which such court shall deem 
proper.  Under the DGCL, to the extent that a director, officer, employee 
or agent is successful, on the merits or otherwise, in the defense of any 
action, suit or proceeding or any claim, issue or matter therein (whether 
or not the suit is brought by or in the right of the corporation), he or 
she shall be indemnified against expenses (including attorneys' fees) 
actually and reasonably incurred by him or her.  In all cases in which 
indemnification is permitted (unless ordered by a court), it may be made 
by the corporation only as authorized in the specific case upon a 
determination that the applicable standard of conduct has been met by the 
party to be indemnified.  The determination must be made by a majority 
vote of a quorum consisting of the directors who were not parties to the 
action or, if such a quorum is not obtainable, or even if obtainable, if a 
quorum of disinterested directors so directs, by independent legal counsel 
in a written opinion, or by the shareholders.  The statute authorizes the 
corporation to pay expenses incurred by an officer or director in advance 
of a final disposition of a proceeding upon receipt of an undertaking by 
or on behalf of the person to whom the advance will be made, to repay the 
advances if it shall ultimately be determined that he was not entitled to 
indemnification.  The DGCL provides that indemnification and advances of 
expenses permitted thereunder are not to be exclusive of any rights to 
which those seeking indemnification or advancement of expenses may be 
entitled under any By-law, agreement, vote of stockholders or 
disinterested directors, or otherwise.  The DGCL also authorizes the 
corporation to purchase and maintain liability insurance on behalf of its 
directors, officers, employees and agents regardless of whether the 
corporation would have the statutory power to indemnify such persons 
against the liabilities insured.
The Amended and Restated Certificate of Incorporation of the 
Registrant (the "Certificate") provides that no director of the Registrant 
shall be personally liable to the Registrant or its stockholders for 
monetary damages for breach of fiduciary duty as a director except for 
liability (i) for any breach of the director's duty of loyalty to the 
Registrant or its stockholders, (ii) for acts or omissions not in good 
faith or which involve intentional misconduct or a knowing violation of 
law, (iii) for paying a dividend or approving a stock repurchase in 
violation of Section 174 of the DGCL or (iv) for any transaction from 
which the director derived an improper personal benefit.

            In addition, the Certificate provides that directors, officers 
and others shall be indemnified to the fullest extent authorized by the 
DGCL, as in effect (or, to the extent indemnification is broadened, as it 
may be amended), against any and all expense, liability and loss 
(including settlement) reasonably incurred or suffered by such person in 
connection with such service.  The Certificate further provides that, to 
the extent permitted by law, expenses so incurred by any such person in 
defending any such proceeding shall, at his request, be paid by the 
Registrant in advance of the final disposition of such action or 
proceeding.

            The Certificate provides that the right to indemnification and 
the payment of expenses incurred in defending a proceeding in advance of 
its final disposition shall not be exclusive of any other right which any 
person may have or acquire under any law, provision of By-laws or 
otherwise.

            Pursuant to indemnification agreements with certain of its 
executive officers and directors, the Registrant has agreed to indemnify 
such persons (including their respective heirs, executors and 
administrators) to the fullest extent permitted by the DGCL against all 
expenses and liabilities reasonably incurred in connection with or arising 
out of any action, suit or proceeding in which such executive officer or 
director may be involved by reason of having been a director or officer of 
the Registrant or any subsidiary thereof.

            The Registrant maintains directors and officers liability and 
company reimbursement insurance which, among other things (i) provides for 
payment on behalf of its officers and directors against loss as defined in 
the policy stemming from acts committed by directors and officers in their 
capacity as such and (ii) provides for payment on behalf of the Registrant 
against such loss but only when the Registrant shall be required or 
permitted to indemnify directors or officers for such loss pursuant to 
statutory or common law or pursuant to duly effective certificate of 
incorporation or by-law provisions.
Item 7.     Exemption from Registration Claimed.

              Not applicable.

Item 8.     Exhibits

     The following exhibits are filed as part of this registration 
statement:

     5.1   Opinion of Shereff, Friedman, Hoffman & Goodman, LLP.

    23.1   Consent of Arthur Andersen LLP.

    23.2   Consent of Shereff, Friedman, Hoffman & Goodman, LLP (included 
           in Exhibit 5.1).

    24     Power of Attorney (included in signature page to this 
           registration statement).

Item 9.     Undertakings.

     (a)  The undersigned Registrant hereby undertakes:

          (1)  To file, during any period in which offers or sales are 
               being made, a post-effective amendment to this 
               registration statement:

                (i) To include any prospectus required by Section 
                    10(a)(3) of the Securities Act of 1933;

               (ii) To reflect in the prospectus any facts or events 
                    arising after the effective date of the 
                    registration statement (or the most recent post-
                    effective amendment thereof) which, individually
                    or in the aggregate, represent a fundamental 
                    change in the information set forth in the 
                    registration statement;

              (iii) To include any material information with respect 
                    to the plan of distribution not previously 
                    disclosed in the registration statement or any 
                    material change to such information in the 
                    registration statement;
PROVIDED, HOWEVER, that paragraphs (a)(1)(i) and (ii) do not 
apply if the registration statement is on Form S-3 or S-8 and the 
information required to be included in a post-effective amendment by those 
paragraphs is contained in periodic reports filed by the Registrant 
pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 
1934 that are incorporated by reference in the registration statement.

          (2)  That, for the purpose of determining any liability 
under the Securities Act of 1933, each such post-effective amendment shall 
be deemed to be a new registration statement relating to the securities 
offered therein, and the offering of such securities at that time shall be 
deemed to be the initial bona fide offering thereof.

          (3)  To remove from registration by means of a post-effective 
amendment any of the securities being registered which remain unsold at 
the termination of the offering.

(b)     The undersigned Registrant hereby undertakes that, for the 
purposes of determining any liability under the Securities Act of 1933, 
each filing of the Registrant's annual report pursuant to Section 13(a) or 
15(d) of the Securities Exchange Act of 1934 (and, where applicable, each 
filing of an employee benefit plan's annual report pursuant to Section 
15(d) of the Securities Exchange Act of 1934) that is incorporated by 
reference in the registration statement shall be deemed to be a new 
registration statement relating to the securities offered therein, and the 
offering of such securities at that time shall be deemed to be the initial 
bona fide offering thereof.

(c)     Insofar as indemnification for liabilities arising under the 
Securities Act of 1933 may be permitted to directors, officers and 
controlling persons of the Registrant pursuant to the foregoing 
provisions, or otherwise, the Registrant has been advised that in the 
opinion of the Securities and Exchange Commission such indemnification is 
against public policy as expressed in the Act and is, therefore, 
unenforceable.  In the event that a claim for indemnification against such 
liabilities (other than the payment by the Registrant of expenses incurred 
or paid by a director, officer or controlling person of the Registrant in 
the successful defense of any action, suit or proceeding) is asserted by 
such director, officer or controlling person in connection with the 
securities being registered, the Registrant will, unless in the opinion of 
its counsel the matter has been settled by controlling precedent, submit 
to a court of appropriate jurisdiction the question whether such 
indemnification by it is against public policy as expressed in the Act and 
will be governed by the final adjudication of such issue.
SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, the 
Registrant certifies that it has reasonable grounds to believe that it 
meets all the requirements for filing on Form S-8 and has duly caused this 
Registration Statement to be signed on its behalf by the undersigned, 
thereunto duly authorized, in the City of Clarkson, State of Georgia, on 
this 30th day of July, 1996.

                               SEROLOGICALS CORPORATION

                               By:  /s/ Harold J. Tenoso          
                                    Harold J. Tenoso, Ph.D.	
                                    President, Chief Executive Officer
                                     and Director

     KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned whose 
signature appears below constitutes and appoints Harold J. Tenoso, Ph.D. 
and Russell H. Plumb, and each of them (with full power of each of them to 
act alone), his true and lawful attorneys-in-fact, with full power of 
substitution and resubstitution for him and on his behalf, and in his 
name, place and stead, in any all capacities to execute and sign any and 
all amendments or post-effective amendments to this registration 
statement, and to file the same, with all exhibits thereto, and other 
documents in connection therewith, with the Securities and Exchange 
Commission, hereby ratifying and confirming all that said attorneys-in-
fact or any of them or their or his substitute or substitutes, may 
lawfully do or cause to be done by virtue hereof and the Registrant hereby 
confers like authority on its behalf.

     Pursuant to the requirements of the Securities Act of 1933, the 
Registration Statement has been signed below by the following persons on 
behalf of the Registrant and in the capacities and on the dates indicated.

Signature                            Title                        Date

 /s/ Harold J. Tenoso           President, Chief Executive     Aug. 2 1996
- ---------------------           Officer and Director
Harold J. Tenoso, Ph.D.         (Prinicpal Executive Officer)

 /s/ Samuel A. Penninger, Jr.   Chairman of the Board of       Aug. 2 1996
- ----------------------------    Directors
Samuel A. Penninger, Jr.

 /s/ Marcia T. Bates            Director                       Aug. 2 1996
- --------------------
Marcia T. Bates

 /s/ James L. Currie            Director                       Aug. 2 1996
- --------------------
James L. Currie

 /s/ George M. Shaw             Director                       Aug. 2 1996
- -------------------
George M. Shaw, M.D., Ph.D.

/s/ Lawrence E. Tilton          Director                       Aug. 2 1996
- -----------------------
Lawrence E. Tilton

 /s/ Matthew C. Weisman         Director                       Aug. 2 1996
- -----------------------
Matthew C. Weisman

 /s/ Russell H. Plumb           Vice President, Finance and    Aug. 2 1996
- ---------------------           Administration and Chief 
Russell H. Plumb                Financial Officer (Principal
                                Financial and Accounting Officer)
SEROLOGICALS CORPORATION

                                 FORM S-8
                         REGISTRATION STATEMENT

                              EXHIBIT INDEX

                                                              Sequentially
                                                                  Numbered
Exhibit                                                             Page

5.1     Opinion of Shereff, Friedman, Hoffman & Goodman, LLP.	

23.1    Consent of Arthur Andersen LLP.	

23.2    Consent of Shereff, Friedman, Hoffman & Goodman, LLP 
        (included in Exhibit 5.1).

24      Power of Attorney (included in signature page to this
        registration statement).